Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 25,000 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale EVP, Chief Commercial Officer sold 14,519 shares at an average $1.14 ($16,496)
  9. 4 Open-market sale EVP & Chief Financial Officer sold 12,628 shares at an average $1.14 ($14,338)
  10. 4 Open-market sale CEO, President sold 52,894 shares at an average $1.14 ($60,082)
  11. 4 Grant or award EVP, GC, CCO & Corp Sec acquired 209,000 shares (grant or award)
  12. 4 Grant or award CEO, President acquired 400,000 shares (grant or award)
  13. 4 Grant or award EVP, Chief Commercial Officer acquired 209,000 shares (grant or award)
  14. 4 Grant or award EVP & Chief Financial Officer acquired 209,000 shares (grant or award)
  15. 4 Grant or award Director acquired 25,000 shares (grant or award)
  16. 4 Grant or award Director acquired 25,000 shares (grant or award)
  17. 4 Grant or award Director acquired 25,000 shares (grant or award)
  18. 4 Grant or award Director acquired 25,000 shares (grant or award)
  19. 4 Grant or award Director acquired 25,000 shares (grant or award)
  20. 4 Grant or award Director acquired 25,000 shares (grant or award)

Page 5 of 34 · 664 filings